ARTICLE | Clinical News
Modified retrovirus: The trial will begin on final approval from the FDA.
June 13, 1994 7:00 AM UTC
University of Pittsburg Medical Center Product: Modified retrovirus bearing the gene for interleukin-1 receptor antagonist protein (IRAP) Indication: Rheumatoid arthritis Status: University researche...